Terms: = Prostate cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272 AND Prognosis
4 results:
1. Upregulation of miR-130b Contributes to Risk of Poor prognosis and Racial Disparity in African-American prostate cancer.
Hashimoto Y; Shiina M; Dasgupta P; Kulkarni P; Kato T; Wong RK; Tanaka Y; Shahryari V; Maekawa S; Yamamura S; Saini S; Deng G; Tabatabai ZL; Majid S; Dahiya R
Cancer Prev Res (Phila); 2019 Sep; 12(9):585-598. PubMed ID: 31266828
[TBL] [Abstract] [Full Text] [Related]
2. Novel biomarkers for prostate cancer including noncoding transcripts.
Romanuik TL; Ueda T; Le N; Haile S; Yong TM; Thomson T; Vessella RL; Sadar MD
Am J Pathol; 2009 Dec; 175(6):2264-76. PubMed ID: 19893039
[TBL] [Abstract] [Full Text] [Related]
3. Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation.
Padar A; Sathyanarayana UG; Suzuki M; Maruyama R; Hsieh JT; Frenkel EP; Minna JD; Gazdar AF
Clin Cancer Res; 2003 Oct; 9(13):4730-4. PubMed ID: 14581343
[TBL] [Abstract] [Full Text] [Related]
4. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features.
Maruyama R; Toyooka S; Toyooka KO; Virmani AK; Zöchbauer-Müller S; Farinas AJ; Minna JD; McConnell J; Frenkel EP; Gazdar AF
Clin Cancer Res; 2002 Feb; 8(2):514-9. PubMed ID: 11839671
[TBL] [Abstract] [Full Text] [Related]
